Characterization of the population that consults by epistaxis to the Otolaryngology Service of the Hospital Universitario Mayor Méderi (HUM)

Article Sidebar

PDF (Español (España))
Published: Sep 30, 2020
DOI: https://doi.org/10.37076/acorl.v48i3.493
Keywords:
epistaxis, demografía, terapeútica, hipertensión. epistaxis, demography, therapeutics, hypertension

Main Article Content

Liliana Isabel Alfaro Arias
Ninguna
Mary Lourdes Hernández López
Jose Alejandro Daza Vergára

Abstract

Introduction: Epistaxis is one of the main reasons for emergency consultation in the Otolaryngology department. Most episodes originate in the anterior nasal septum and their management tends to be conservative. Objective: To characterize the population that consults for epistaxis at the Otolaryngology service of the Hospital Universitario Mayor Méderi (HUM) between March 2017 and February 2018. Methodology: Observational, descriptive, cross-sectional study, with retrospective data collection of patients admitted to the HUM emergency room for epistaxis, registered in the Otolaryngology service database. Demographic data, location of bleeding, treatment, comorbidities, drugs and blood pressure were analyzed.


 

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Alfaro Arias LI, Hernández López ML, Daza Vergára JA. Characterization of the population that consults by epistaxis to the Otolaryngology Service of the Hospital Universitario Mayor Méderi (HUM). Acta otorrinolaringol cir cabeza cuello [Internet]. 2020Sep.30 [cited 2025Jan.22];48(3):232 - 238. Available from: https://revista.acorl.org.co/index.php/acorl/article/view/493
Issue
Vol. 48 No. 3 (2020): Julio - Septiembre
Section
Trabajos Originales

Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.

Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.

eISSN: 2539-0856

ISSN: 0120-8411

References

Bequignon E, Vérillaud B, Robard L, Michel J, Prulière Escabasse V, Crampette L, et al. Guidelines of the French

Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(3):185-9. doi:10.1016/j.anorl.2016.09.008

Al-bar MH. Epistaxis and catastrophic nasal bleeding. OperTech Otolaryngol - Head Neck Surg. 2014;25(2):194-200. doi:10.1016/j.otot.2014.02.010

Davies K, Batra K, Mehanna R, Keogh I. Pediatric epistaxis:epidemiology, management & impact on quality of life. Int JPediatr Otorhinolaryngol. 2014;78(8):1294-97. doi:10.1016/j.ijporl.2014.05.013

Kasperek ZA, Pollock GF. Epistaxis: an overview. Emerg Med Clin North Am. 2013;31(2):443-454. doi:10.1016/j.

emc.2013.01.008

Kindler RM, Holzmann D, Landis BN, Ditzen B, Soyka MB. The high rate of long-term recurrences and sequelae after epistaxis treatment. Auris Nasus Larynx. 2016;43(4):412-7.doi:10.1016/j.anl.2015.09.011

Verillaud B, Robard L, Michel J, Pruliere Escabasse V, Béquignon E, et al. Guidelines of the French Society of

Otorhinolaryngology (SFORL). Second-line treatment ofepistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis.2017;134(3):191-193. doi:10.1016/j.anorl.2016.09.009

Lin G, Bleier B. Surgical Management of Severe Epistaxis.Otolaryngol Clin North Am. 2016;49(3):627-37. doi:10.1016/j.otc.2016.01.003

Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz- Romero B, Gras-Albert JR. Epidemiología de las epistaxisingresadas en un hospital de tercer nivel. Acta OtorrinolaringolEsp. 2010;61(1):41–7.

Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ,Camargo CA Jr. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77-81.doi:10.1016/j.annemergmed.2004.12.014

Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg. 2006;64(3):511-518.doi:10.1016/j.joms.2005.11.031

Ando Y, Iimura J, Arai S, et al. Risk factors for recurrent epistaxis: importance of initial treatment. Auris Nasus Larynx.2014;41(1):41-45. doi:10.1016/j.anl.2013.05.004

Corr MJ, Tikka T, Douglas CM, Marshall J. One-year all-cause mortality for 338 patients admitted with epistaxis in a largetertiary ENT centre. J Laryngol Otol. 2019;133(6):487-493.doi:10.1017/S0022215119000860

Newton E, Lasso A, Petrcich W, Kilty SJ. An outcomes analysis of anterior epistaxis management in the emergency department. J Otolaryngol Head Neck Surg. 2016;45:24. doi:10.1186/s40463-016-0138-2

Kubba H, MacAndie C, Botma M, et al. A prospective, singleblind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood. Clin Otolaryngol Allied Sci.2001;26(6):465-468. doi:10.1046/j.1365-2273.2001.00502.x

Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH. Risk factors for recurrent spontaneous epistaxis. Mayo Clin Proc. Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello. 2020; 48(3): 44(2): 92-99 33 2014;89(12):1636-1643. doi:10.1016/j.mayocp.2014.09.009

Terakura M, Fujisaki R, Suda T, Sagawa T, Sakamoto T.Relationship between blood pressure and persistent epistaxis at the emergency department: a retrospective study. J Am Soc Hypertens. 2012;6(4):291-295. doi:10.1016/j.jash.2012.05.001

Lubianca Neto JF, Fuchs FD, Facco SR, et al. Is epistaxis evidence of end-organ damage in patients with

hypertension?. Laryngoscope. 1999;109(7 Pt 1):1111-15.doi:10.1097/00005537-199907000-00019

Min HJ, Kang H, Choi GJ, Kim KS. Association between Hypertension and Epistaxis: Systematic Review and Metaanalysis. Otolaryngol Head Neck Surg. 2017;157(6):921-927.doi:10.1177/0194599817721445